RD-12 is the product of a three-way cross between Big Bud, Shiva, and a Hawaiian indica. This rare hybrid carries an unmistakable indica-leaning profile, even as some records suggest a roughly equal sativa/indica balance. Although not widely cultivated, it has surfaced in regulated markets in California and the western United States as a niche offering.
Potency centers on a robust profile, with THC commonly around 16 percent in available tests, while CBD remains near zero (about 0.03%). The high is predominantly physical: a notable body buzz, deep relaxation, couch-lock, and a tendency toward sleepiness, making it a potential aid for sleeplessness. It can also address chronic pain, migraines, and inflammation, though the very low CBD means it should not be relied on as the sole treatment for CBD-responsive conditions such as epilepsy.
Flavors unfold as a sweet-earthy palate with woody undertones, and the aroma blends blueberry notes with a Skunk edge. In practice, RD-12 tends toward earthy, woody sweetness paired with a pungent, fruity character. Side effects are typically mild and infrequent due to its rarity, though dry mouth and dry eyes, along with occasional paranoia, can occur when consumed in larger amounts.